166 related articles for article (PubMed ID: 35717443)
1. Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells.
Riess C; Del Moral K; Fiebig A; Kaps P; Linke C; Hinz B; Rupprecht A; Frank M; Fiedler T; Koczan D; Troschke-Meurer S; Lode HN; Engel N; Freitag T; Classen CF; Maletzki C
Cell Death Dis; 2022 Jun; 13(6):555. PubMed ID: 35717443
[TBL] [Abstract][Full Text] [Related]
2. PEGylation increases antitumoral activity of arginine deiminase of Streptococcus pyogenes.
Schwarz R; Zitzow E; Fiebig A; Hering S; Humboldt Y; Schoenwaelder N; Kämpfer N; Volkmar K; Hinz B; Kreikemeyer B; Maletzki C; Fiedler T
Appl Microbiol Biotechnol; 2022 Jan; 106(1):261-271. PubMed ID: 34910240
[TBL] [Abstract][Full Text] [Related]
3. The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C.
Linke C; Freitag T; Riess C; Scheffler JV; Del Moral K; Schoenwaelder N; Fiedler T; Fiebig A; Kaps P; Dubinski D; Schneider B; Bergmann W; Classen CF; Maletzki C
Cancer Cell Int; 2023 Feb; 23(1):38. PubMed ID: 36843002
[TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models.
Riess C; Koczan D; Schneider B; Linke C; Del Moral K; Classen CF; Maletzki C
Cell Death Discov; 2021 Mar; 7(1):54. PubMed ID: 33723248
[TBL] [Abstract][Full Text] [Related]
5. Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo.
Fiedler T; Strauss M; Hering S; Redanz U; William D; Rosche Y; Classen CF; Kreikemeyer B; Linnebacher M; Maletzki C
Cancer Biol Ther; 2015; 16(7):1047-55. PubMed ID: 25774632
[TBL] [Abstract][Full Text] [Related]
6. Deciphering molecular mechanisms of arginine deiminase-based therapy - Comparative response analysis in paired human primary and recurrent glioblastomas.
Maletzki C; Rosche Y; Riess C; Scholz A; William D; Classen CF; Kreikemeyer B; Linnebacher M; Fiedler T
Chem Biol Interact; 2017 Dec; 278():179-188. PubMed ID: 28989041
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction RAD51, and Ku80 proteolysis promote apoptotic effects of Dinaciclib in Bcl-xL silenced cells.
Premkumar DR; Jane EP; Thambireddy S; Sutera PA; Cavaleri JM; Pollack IF
Mol Carcinog; 2018 Apr; 57(4):469-482. PubMed ID: 29240261
[TBL] [Abstract][Full Text] [Related]
8. Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells.
Khoury O; Ghazale N; Stone E; El-Sibai M; Frankel AE; Abi-Habib RJ
J Neurooncol; 2015 Mar; 122(1):75-85. PubMed ID: 25567351
[TBL] [Abstract][Full Text] [Related]
9. The Individual Effects of Cyclin-Dependent Kinase Inhibitors on Head and Neck Cancer Cells-A Systematic Analysis.
Schoenwaelder N; Salewski I; Engel N; Krause M; Schneider B; Müller M; Riess C; Lemcke H; Skorska A; Grosse-Thie C; Junghanss C; Maletzki C
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34063457
[TBL] [Abstract][Full Text] [Related]
10. Autophagy inhibition potentiates SAHA‑mediated apoptosis in glioblastoma cells by accumulation of damaged mitochondria.
Lohitesh K; Saini H; Srivastava A; Mukherjee S; Roy A; Chowdhury R
Oncol Rep; 2018 Jun; 39(6):2787-2796. PubMed ID: 29658588
[TBL] [Abstract][Full Text] [Related]
11. Selective but not pan-CDK inhibition abrogates 5-FU-driven tissue factor upregulation in colon cancer.
Kayser A; Wolff A; Berlin P; Duehring L; Henze L; Mundkowski R; Bergmann W; Müller-Hilke B; Wagner C; Huehns M; Oehmcke-Hecht S; Maletzki C
Sci Rep; 2024 May; 14(1):10582. PubMed ID: 38719932
[TBL] [Abstract][Full Text] [Related]
12. Combining an Autophagy Inhibitor, MPT0L145, with Abemaciclib Is a New Therapeutic Strategy in GBM Treatment.
Hsieh TH; Liang ML; Zheng JH; Lin YC; Yang YC; Vo TH; Liou JP; Yen Y; Chen CH
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885226
[TBL] [Abstract][Full Text] [Related]
13. Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking.
Zhao B; Shen C; Zheng Z; Wang X; Zhao W; Chen X; Peng F; Xue L; Shu M; Hou X; Wang K; Zhong C; Sun J; Wan J; Zhao S
Cell Physiol Biochem; 2018; 51(4):1566-1583. PubMed ID: 30497066
[TBL] [Abstract][Full Text] [Related]
14. Activation of the Unfolded Protein Response via Inhibition of Protein Disulfide Isomerase Decreases the Capacity for DNA Repair to Sensitize Glioblastoma to Radiotherapy.
Liu Y; Ji W; Shergalis A; Xu J; Delaney AM; Calcaterra A; Pal A; Ljungman M; Neamati N; Rehemtulla A
Cancer Res; 2019 Jun; 79(11):2923-2932. PubMed ID: 30996048
[TBL] [Abstract][Full Text] [Related]
15. Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib.
Riess C; Schneider B; Kehnscherper H; Gesche J; Irmscher N; Shokraie F; Classen CF; Wirthgen E; Domanska G; Zimpfer A; Strüder D; Junghanss C; Maletzki C
Front Immunol; 2020; 11():55. PubMed ID: 32117235
[TBL] [Abstract][Full Text] [Related]
16. Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer.
Howard D; James D; Garcia-Parra J; Pan-Castillo B; Worthington J; Williams N; Coombes Z; Rees SC; Lutchman-Singh K; Francis LW; Rees P; Margarit L; Conlan RS; Gonzalez D
Front Oncol; 2022; 12():1014280. PubMed ID: 36505806
[TBL] [Abstract][Full Text] [Related]
17. The Renaissance of CDK Inhibitors in Breast Cancer Therapy: An Update on Clinical Trials and Therapy Resistance.
Abdelmalak M; Singh R; Anwer M; Ivanchenko P; Randhawa A; Ahmed M; Ashton AW; Du Y; Jiao X; Pestell R
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358806
[TBL] [Abstract][Full Text] [Related]
18. Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP.
Mantena SK; Sharma SD; Katiyar SK
Carcinogenesis; 2006 Oct; 27(10):2018-27. PubMed ID: 16621886
[TBL] [Abstract][Full Text] [Related]
19. A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition.
Alagpulinsa DA; Ayyadevara S; Yaccoby S; Shmookler Reis RJ
Mol Cancer Ther; 2016 Feb; 15(2):241-50. PubMed ID: 26719576
[TBL] [Abstract][Full Text] [Related]
20. OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins.
Hamed HA; Yacoub A; Park MA; Eulitt P; Sarkar D; Dimitrie IP; Chen CS; Grant S; Curiel DT; Fisher PB; Dent P
Cancer Biol Ther; 2010 Apr; 9(7):526-36. PubMed ID: 20107314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
